Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA)
| Autor: | G L Ridgway, Kevin J. Towner, Derek F. J. Brown, Donald Morrison, Michael W. D. Wren, David I. Edwards, Peter M. Hawkey |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Microbiology (medical)
Staphylococcus aureus medicine.medical_specialty Susceptibility testing Micrococcaceae Meticillin medicine.drug_class Antibiotics Microbial Sensitivity Tests Drug resistance medicine.disease_cause Microbiology Internal medicine Drug Resistance Bacterial medicine Humans Pharmacology (medical) Antibacterial agent Pharmacology biology business.industry Glycopeptides Staphylococcal Infections biochemical phenomena metabolism and nutrition bacterial infections and mycoses biology.organism_classification Methicillin-resistant Staphylococcus aureus United Kingdom Anti-Bacterial Agents Infectious Diseases Methicillin Resistance business medicine.drug |
| Zdroj: | Journal of Antimicrobial Chemotherapy. 56:1000-1018 |
| ISSN: | 1460-2091 0305-7453 |
| Popis: | These evidence-based guidelines have been produced after a literature review of the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). We have considered the detection of MRSA in screening samples and the detection of reduced susceptibility to glycopeptides in S. aureus. Recommendations are given for the identification of S. aureus and for suitable methods of susceptibility testing and screening for MRSA and for S. aureus with reduced susceptibility to glycopeptides. These guidelines indicate what tests should be used but not when the tests are applicable, as aspects of this are dealt with in guidelines on control of MRSA. There are currently several developments in screening media and molecular methods. It is likely that some of our recommendations will require modification as the new methods become available. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|